
The measurement of plasma zzso zzso is useful in assessing compliance, zzso therapy, and minimizing zzso We measured plasma zzso and zzso zzso zzso in samples from zzso patients zzso male, zzso zzso No zzso was detected in zzso samples zzso patients, median prescribed dose 300 zzso In zzso zzso zzso samples zzso zzso plasma zzso concentration ranged from 10 to 350 zzso backward multiple zzso analysis zzso % of the total zzso of zzso plasma zzso concentration against zzso zzso dose zzso age zzso sex zzso zzso 0, female zzso 1), cigarette smoking habit zzso zzso zzso smokers zzso 1), body weight zzso and plasma zzso ratio zzso zzso ratio, zzso showed that these zzso explained zzso of the observed variation in plasma zzso concentration zzso zzso zzso zzso zzso zzso zzso zzso according to the following zzso log 10 zzso zzso zzso log 10 zzso + zzso zzso + zzso X 10 zzso zzso + zzso zzso 10 zzso zzso + zzso zzso zzso zzso - zzso zzso zzso - zzso This model and its associated confidence intervals were used to develop zzso of plasma zzso concentration versus dose for male and female smokers and zzso zzso plasma zzso changes by zzso in nonsmokers, zzso in zzso zzso % for every zzso change in MR zzso zzso zzso for every 5 years zzso 40 zzso and zzso % for every 10 zzso body weight zzso 80 zzso The zzso can be used zzso to zzso dosage to achieve a given target plasma zzso zzso and zzso for quantitative evaluation of adherence by zzso the likelihood of an observed concentration being achieved by a given dosage zzso The model has been validated against published zzso 

